Would you consider the use of romosozumab in men who have failed therapy with teriparatide and sustained multiple vertebral fractures?

In what clinical scenarios would you consider prescribing romosozumab after PTH analogue therapy in men with severe osteoporosis?

• Men who continue to sustain vertebral fractures
• Men with no bone mineral density change on DEXA
• Men with no change in bone turnover markers
• I would not consider romosozumab since it is not FDA approved for use in men
• Other